ResearchLongitudinal Changes in Serum Urate Levels From Premenopause Through Postmenopause: Interrupted Time-Series Analyses
ResearchCharacterizing Adherence to a Mobile Health App for Patient-Reported Outcomes in Rheumatoid Arthritis
ResearchEffectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort study
ResearchLongitudinal patterns of C-reactive protein values in calcium pyrophosphate deposition disease
ResearchGout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)
ResearchDisease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study
ResearchSystematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states—A G-CAN consensus project
ResearchCore domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus
ResearchCore domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus
ResearchCoronary artery calcium and atherosclerotic cardiovascular disease risk scores in patients with calcium pyrophosphate deposition disease
ResearchPseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?—The time has come to reconsider the nomenclature of calcium pyrophosphate deposition
ResearchGenome-wide association study in chondrocalcinosis reveals ENPP1 as a candidate therapeutic target in calcium pyrophosphate deposition disease